Patients With Moderate COPD Also Benefit From Triple Therapy medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Date Time
Ohio State researchers name 19 genes associated with heart muscle disease
COLUMBUS, Ohio – Researchers at The Ohio State University Wexner Medical Center led an international group of experts that worked together to classify 19 genes associated with dilated cardiomyopathy (DCM) as having high impact on the heart muscle disease.
Researchers believe most of DCM has a genetic background, and at least 30% of people with DCM have a family member with the disease. First-degree family members (daughters, sons, brothers, sisters and parents) of a patient with DCM are encouraged to undergo genetic testing for the disease. However, current genetic testing panels analyze dozens, sometimes hundreds of genes, and they often have limited scientific support, making genetic results clinically difficult to interpret.
COLUMBUS, Ohio – Researchers at The Ohio State University Wexner Medical Center have new insights into how the heart’s sinoatrial node (SAN), the body’s natural pacemaker, and its electrical signals are affected during heart failure.
Ohio State Researchers Examine How Fibrosis Affects Heart s Natural Pacemaker miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors
February 17, 2021 08:00 ET | Source: scPharmaceuticals, Inc. scPharmaceuticals, Inc. Burlington, Massachusetts, UNITED STATES
BURLINGTON, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the appointment of William T. Abraham, M.D., to the company’s Board of Directors. Dr. Abraham currently serves as Professor of Internal Medicine (Cardiology), Physiology and Cell Biology and College of Medicine Distinguished Professor at The Ohio State University as well as Chief Medical Officer at V-Wave Ltd., a privately held developer of percutaneous implantable therapeutic devices for